Applying the radioactive eraser: I-131 to ablate normal thyroid tissue in patients from whom thyroid cancer has been resected

Journal Article · Mon Aug 01 04:00:00 EDT 1983 · J. Nucl. Med.; (United States)

OSTI ID:5895826

Sisson, J C

An editorial describing the use of I-131 in thyroid cancer is presented. As a treatment for functioning thyroid cancer, radioiodine is compelling. Iodine-131 will destroy thyroid tissues, including well-differentiated cancers. However, the indolent nature of thyroid neoplasms obfuscates the effects of therapy; death rates of papillary carcinomas range from 1.0% to 11.5% in ten or more years of follow-up. Moreover, the use of thyroidectomy and thyroid hormone as well as radioiodine have confounded analyses of treatments. No wonder that investigators have sought more readily available indices of therapeutic benefits. And in this milieu, scintigrams have come to be worshipped as portents and as arbiters of proper treatment.

• Research Organization: Univ. of Michigan, Ann Arbor
• OSTI ID: 5895826
• Journal Information: J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 24:8; ISSN JNMEA
• Country of Publication: United States
• Language: English

Related Subjects

550604 -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
560151* -- Radiation Effects on Animals-- Man
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
BODY
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC TECHNIQUES
DISEASES
DOSES
ENDOCRINE GLANDS
GLANDS
INTERMEDIATE MASS NUCLEI
IODINE 131
IODINE ISOTOPES
ISOTOPES
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANS
PATIENTS
RADIATION DOSES
RADIATION EFFECTS
RADIOISOTOPE SCANNING
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
SCINTISCANNING
SIDE EFFECTS
THERAPY
THYROID